Free Radicals in Health and Disease

Abstract

Free radicals, molecules with unpaired electrons, are double-edged swords. While they may cause damages to cells and threaten human health, they play essential roles in cellular signaling toward mitochondrial and immune homeostasis. Overproduction or insufficient supply of free radicals can both lead to health concerns and disease syndromes by causing oxidative or reductive stress to cells. Current redox therapies frequently fail clinically due to imprecise dosing and targeting, causing therapeutic futility or paradoxical harm by disrupting redox homeostasis, necessitating integrated frameworks linking redox biology to precision interventions alongside therapeutic innovation. This review explores free radicals’ generation sources, characterizes mitochondrial oxidative phosphorylation and pathological hyperglycemia as pivotal endogenous sources, and proposes oxygen and transition metals as fundamental regulators. This paper synthesizes multidimensional molecular mechanisms and pathologies arising from redox dysregulation and establishes reductive stress as a critical pathogenesis driver alongside oxidative stress. This review discusses free radical approaches and proposes cold atmospheric plasma as a transformative redox-modulating technology capable of bridging therapeutic dichotomies through calibrated interventions. By integrating mechanistic insights with innovative methodologies, this work underscores the imperative to innovatively harness the dual nature of free radicals for precision health and disease management.

Keywords

cancer / cold atmospheric plasma / degeneration disease / free radicals / oxidative stress / reductive stress

References

[1] A. Supawat , N. Palachai, and J. Jittiwat, “Effect of Galangin on Oxidative Stress, Antioxidant Defenses and Mitochondrial Dynamics in a Rat Model of Focal Cerebral Ischemia,” Biomedical Reports 22, no. 1 (2025): 10.

[2] S.-K. Wu, L.e Wang, F. Wang, and J. Zhang, “Resveratrol Improved Mitochondrial Biogenesis by Activating SIRT1/PGC-1α Signal Pathway in SAP,” Scientific Reports 14, no. 1 (2024): 26216.

[3] P. V. Gade, A. V. R. Rivera, L. Hasanzadah, et al., “Secretory Mitophagy: An Extracellular Vesicle-mediated Adaptive Mechanism for Cancer Cell Survival Under Oxidative Stress,” Frontiers in Cell and Developmental Biology 12 (2024): 1490902.

[4] S. Liu, B. Huang, J. Cao, et al., “ROS Fine-tunes the Function and Fate of Immune Cells,” International Immunopharmacology 119 (2023): 110069.

[5] A. B. Jena , R. R. Samal, N. K. Bhol, and A. K. Duttaroy, “Cellular Red-Ox System in Health and Disease: The Latest Update,” Biomedicine & Pharmacotherapy 162 (2023): 114606.

[6] S. K. Ray, E. Jayashankar, A. Kotnis, and S. Mukherjee, “Oxidative versus Reductive Stress in Breast Cancer Development and Cellular Mechanism of Alleviation: A Current Perspective With Anti-breast Cancer Drug Resistance,” Current Molecular Medicine 24, no. 2 (2024): 205-216.

[7] C. Tawada, Y. Ueda, Y. Mizutani, X. Zang, K. Tanaka, and H. Iwata, “Oxidative Stress and Generalised Pustular Psoriasis: Report of D- ROM Measurements in Nine Cases Including Three of Pustular Psoriasis of Pregnancy,” Experimental Dermatology 34, no. 3 (2025): e70076.

[8] M. G. Rossino, R. Amato, M. Amadio, et al., “A Nature-Inspired Nrf2 Activator Protects Retinal Explants From Oxidative Stress and Neurodegeneration,” Antioxidants 10, no. 8 (2021): 1296.

[9] S.-S. Liu, L.i-L.i Xu, S. Fan, et al., “Effect of Platelet-Rich Plasma Injection Combined With Individualised Comprehensive Physical Therapy on Temporomandibular Joint Osteoarthritis: A Prospective Cohort Study,” Journal of Oral Rehabilitation 49, no. 2 (2022): 150-159.

[10] P. Bharadwaj, N. Wijesekara, M. Liyanapathirana, et al., “The Link Between Type 2 Diabetes and Neurodegeneration: Roles for Amyloid-β, Amylin, and Tau Proteins,” Journal of Alzheimer's Disease 59, no. 2 (2017): 421-432.

[11] T. Persson , B. O. Popescu, and A. Cedazo-Minguez, “Oxidative Stress in Alzheimer's Disease: Why Did Antioxidant Therapy Fail?,” Oxidative Medicine and Cellular Longevity 2014 (2014): 1-11.

[12] D. R. Galasko, E. Peskind, C. M. Clark, et al., “Antioxidants for Alzheimer Disease,” Archives of Neurology 69, no. 7 (2012): 836-841.

[13] A. Chan , R. Remington, E. Kotyla, A. Lepore, J. Zemianek, and T. B. Shea, “A Vitamin/Nutriceutical Formulation Improves Memory and Cognitive Performance in Community-dwelling Adults Without Dementia,” The Journal of Nutrition, Health & Aging 14, no. 3 (2010): 224-230.

[14] Antioxidant Status and Neovascular Age-Related Macular Degeneration. Archives of Ophthalmology 1993. 111(1): 104.

[15] M. Banerjee , R. Chawla, and A. Kumar, “Antioxidant Supplements in Age-related Macular Degeneration: Are They Actually Beneficial?,” Therapeutic Advances in Ophthalmology 13 (2021): 25158414211030418.

[16] G. S. Omenn, G. E. Goodman, M. D. Thornquist, et al., “Effects of a Combination of Beta Carotene and Vitamin A on Lung Cancer and Cardiovascular Disease,” New England Journal of Medicine 334, no. 18 (1996): 1150-1155.

[17] J. Kordiak, F. Bielec, S. Jabłoński, and D. Pastuszak-Lewandoska, “Role of Beta-Carotene in Lung Cancer Primary Chemoprevention: A Systematic Review With Meta-Analysis and Meta-Regression,” Nutrients 14, no. 7 (2022): 1361.

[18] M. Woldeselassie and A. Tamene, “Therapeutic Controversies Over Use of Antioxidant Supplements During Cancer Treatment: A Scoping Review,” Frontiers in Nutrition 11 (2024): 1480780.

[19] X. Dai, K. Bazaka, D. J. Richard, E. (R.) W. Thompson, and K. (.K.). Ostrikov, “The Emerging Role of Gas Plasma in Oncotherapy,” Trends in Biotechnology 36, no. 11 (2018): 1183-1198.

[20] N. Zhang , G. Yang, Y. Wu, et al., “Controlled Release of Cold Atmospheric Plasma by Gelatin Scaffold Enhances Wound Healing via Macrophage Modulation,” ACS Applied Materials & Interfaces 17, no. 10 (2025): 15050-15066.

[21] J. Hu, K. Xie, H. Zhu, et al., “Effects of Atmospheric Cold Plasma Treatment Mode on Muscle Quality and Bacterial Community of Red Shrimp During Cold Storage,” Food Research International 207 (2025): 116051.

[22] X. Dai , L. Shen, and J. Zhang, “Cold Atmospheric Plasma: Redox Homeostasis to Treat Cancers?,” Trends in Biotechnology 41, no. 1 (2023): 15-18.

[23] C. Wu, X. Yang, K. Yang, et al., “Compensatory Effect-based Oxidative Stress Management Microneedle for Psoriasis Treatment,” Bioactive Materials 46 (2025): 229-241.

[24] Y. Xiyang, J.u Gao, M. Ding, et al., “Exacerbated Mitochondrial Dynamic Abnormalities Without Evident Tau Pathology in Rapidly Progressive Alzheimer's Disease,” Journal of Alzheimer's Disease 102, no. 4 (2024): 1074-1083.

[25] R. Z. Zhao , S. Jiang, L. Zhang, and Z. B. Yu, “Mitochondrial Electron Transport Chain, ROS Generation and Uncoupling (Review),” International Journal of Molecular Medicine 44, no. 1 (2019): 3-15.

[26] V. Adam-Vizi and C. Chinopoulos, “Bioenergetics and the Formation of Mitochondrial Reactive Oxygen Species,” Trends in Pharmacological Sciences 27, no. 12 (2006): 639-645.

[27] J. F. Turrens , “Mitochondrial Formation of Reactive Oxygen Species,” Journal of Pharmacological Sciences 552, no. Pt 2 (2003): 335-344.

[28] E. Cadenas and K. J. Davies, “Mitochondrial Free Radical Generation, Oxidative Stress, and aging11This Article Is Dedicated to the Memory of Our Dear Friend, Colleague, and Mentor Lars Ernster (1920-1998), in Gratitude for All he Gave to US.,” Free Radical Biology and Medicine 29, no. 3-4 (2000): 222-230.

[29] M. D. Brand , “Mitochondrial Generation of Superoxide and Hydrogen Peroxide as the Source of Mitochondrial Redox Signaling,” Free Radical Biology and Medicine 100 (2016): 14-31.

[30] A. J. Kowaltowski, N. C. De Souza-Pinto, R. F. Castilho, and A. E. Vercesi, “Mitochondria and Reactive Oxygen Species,” Free Radical Biology and Medicine 47, no. 4 (2009): 333-343.

[31] M. D. Brand , “The Sites and Topology of Mitochondrial Superoxide Production,” Experimental Gerontology 45, no. 7-8 (2010): 466-472.

[32] H. Yaribeygi , S. L. Atkin, and A. Sahebkar, “A Review of the Molecular Mechanisms of Hyperglycemia-Induced Free Radical Generation Leading to Oxidative Stress,” Journal of Cellular Physiology 234, no. 2 (2019): 1300-1312.

[33] M. D. Burman , S. Bag, S. Ghosal, and S. Bhowmik, “Glycation of Proteins and Its End Products: From Initiation to Natural Product-Based Therapeutic Preventions,” ACS Pharmacology & Translational Science 8, no. 3 (2025): 636-653.

[34] S. Fakhruddin , W. Alanazi, and K. E. Jackson, “Diabetes-induced Reactive Oxygen Species: Mechanism of Their Generation and Role in Renal Injury,” Journal of Diabetes Research (2017): 8379327.

[35] J. C. Tobon-Velasco , E. Cuevas, and M. A. Torres-Ramos, “Receptor for AGEs (RAGE) as Mediator of NF-kB Pathway Activation in Neuroinflammation and Oxidative Stress,” CNS & Neurological Disorders—Drug Targets 13, no. 9 (2014): 1615-1626.

[36] R. Medina-Navarro , G. Duran-Reyes, M. Diaz-Flores, J. J. Hicks, and J. Kumate, “Glucose Autoxidation Produce Acrolein From Lipid Peroxidation in Vitro,” Clinica Chimica Acta 337, no. 1-2 (2003): 183-185.

[37] T. K. Das , M. R. Wati, and K. Fatima-Shad, “Oxidative Stress Gated by Fenton and Haber Weiss Reactions and Its Association with Alzheimer's Disease,” Archives of Neuroscience 2, no. 3 (2014): e20078.

[38] Z. Zhao , “Iron and Oxidizing Species in Oxidative Stress and Alzheimer's Disease,” Aging Medicine 2, no. 2 (2019): 82-87.

[39] M. A. Deibel , W. D. Ehmann, and W. R. Markesbery, “Copper, Iron, and Zinc Imbalances in Severely Degenerated Brain Regions in Alzheimer's disease: Possible Relation to Oxidative Stress,” Journal of the Neurological Sciences 143, no. 1-2 (1996): 137-142.

[40] E. Pandur, B. Major, T. Rák, K. Sipos, A. Csutak, and G. Horváth, “Linalool and Geraniol Defend Neurons From Oxidative Stress, Inflammation, and Iron Accumulation in in Vitro Parkinson's Models in in Vitro Parkinson's Models,” Antioxidants 13, no. 8 (2024): 917.

[41] Y. Li, X. Li, M. Zheng, F. Bu, C. Xiang, and F. Zhang, “Puerarin Inhibits HDAC1-induced Oxidative Stress Disorder by Activating JNK Pathway and Alleviates Acrolein-induced Atherosclerosis,” Clinics 79 (2024): 100413.

[42] C. A. Lerner, P. Rutagarama, T. Ahmad, I. K. Sundar, A. Elder, and I. Rahman, “Electronic Cigarette Aerosols and Copper Nanoparticles Induce Mitochondrial Stress and Promote DNA Fragmentation in Lung Fibroblasts,” Biochemical and Biophysical Research Communications 477, no. 4 (2016): 620-625.

[43] B.-Y. Li, H.-Y.u Li, D.-D. Zhou, et al., “Effects of Different Green Tea Extracts on Chronic Alcohol Induced-Fatty Liver Disease by Ameliorating Oxidative Stress and Inflammation in Mice,” Oxidative Medicine and Cellular Longevity 2021 (2021): 5188205.

[44] W. Zhang, J. Yang, J. Liu, et al., “Red Yeast Rice Prevents Chronic Alcohol-Induced Liver Disease by Attenuating Oxidative Stress and Inflammatory Response in Mice,” Journal of Food Biochemistry 45, no. 4 (2021): e13672.

[45] C.-Q. Hu, Q.-L.i Bo, L.-L. Chu, et al., “Vitamin D Deficiency Aggravates Hepatic Oxidative Stress and Inflammation During Chronic Alcohol-Induced Liver Injury in Mice,” Oxidative Medicine and Cellular Longevity 2020 (2020): 1-14.

[46] O.h S. Kwon, S. T. Decker, J. Zhao, et al., “The Receptor for Advanced Glycation End Products (RAGE) Is Involved in Mitochondrial Function and Cigarette Smoke-induced Oxidative Stress,” Free Radical Biology and Medicine 195 (2023): 261-269.

[47] G. Gottschalk, D. Peterson, K. Knox, M. Maynard, R. J. Whelan, and A. Roy, “Elevated ATG13 in Serum of Patients With ME/CFS Stimulates Oxidative Stress Response in Microglial Cells via Activation of Receptor for Advanced Glycation End Products (RAGE),” Molecular and Cellular Neuroscience 120 (2022): 103731.

[48] Y. Yu, L. Wang, F. Delguste, et al., “Advanced Glycation End Products Receptor RAGE Controls Myocardial Dysfunction and Oxidative Stress in High-fat Fed Mice by Sustaining Mitochondrial Dynamics and Autophagy-lysosome Pathway,” Free Radical Biology and Medicine 112 (2017): 397-410.

[49] M. Khazaei, J. Karimi, N. Sheikh, et al., “Effects of Resveratrol on Receptor for Advanced Glycation End Products (RAGE) Expression and Oxidative Stress in the Liver of Rats With Type 2 Diabetes,” Phytotherapy Research 30, no. 1 (2016): 66-71.

[50] E. N. Abd Al Haleem, W. Y. S. Hasan, and H. M. M. Arafa, “Therapeutic Effects of Thymoquinone or Capsaicin on Acrylamide-induced Reproductive Toxicity in Rats Mediated by Their Effect on Oxidative Stress, Inflammation, and Tight Junction Integrity,” Drug and Chemical Toxicology 45, no. 5 (2022): 2328-2340.

[51] X. Dai, Y. Zhou, F. Han, and J. Li, “Succinylation and Redox Status in Cancer Cells,” Frontiers in Oncology 12 (2022): 1081712.

[52] P. G. Gervasi , M. R. Agrillo, A. Lippi, N. Bernardini, R. Danesi, and M. Del Tacca, “Superoxide Anion Production by Doxorubicin Analogs in Heart Sarcosomes and by Mitochondrial NADH Dehydrogenase,” Research Communications in Chemical Pathology and Pharmacology 67, no. 1 (1990): 101-115.

[53] S. Lal-Shahsavar, N. M. Zolbanin, A. Jafari, and M. Ghasemnejad-Berenji, “Metformin Alleviates Doxorubicin-induced Hepatic Damage by Modulating Oxidative Stress: A Molecular, Biochemical, and Histopathological Approach in a Rat Model,” Naunyn-Schmiedeberg's Archives of Pharmacology 398, no. 7 (2025): 9099-9107.

[54] L.i Gao, W.-F. Wu, L. Dong, et al., “Protocatechuic Aldehyde Attenuates Cisplatin-Induced Acute Kidney Injury by Suppressing Nox-Mediated Oxidative Stress and Renal Inflammation,” Frontiers in Pharmacology 7 (2016): 479.

[55] H. Ogata , X. X. Luo, and X. Xu, “Comparison of Effects of Margarite Extract and Recombinant human Superoxide Dismutase on Paraquat-induced Superoxide Anion Radicals in Rat Lung,” Circulatory Shock 43, no. 4 (1994): 161-165.

[56] J.-M. Sun, S. Agarwal, T. D. Desai, et al., “Cryptotanshinone Protects Against Oxidative Stress in the Paraquat-Induced Parkinson's disease Model,” Environmental Toxicology 38, no. 1 (2023): 39-48.

[57] F. Basak , T. Kuşat, Y. Ersan, and T. Kahraman, “Titanium Dioxide-induced Fibrotic Liver Model and the Therapeutic Effect of Resveratrol by Modulation of Alpha-SMA and 8-oHdG Expressions, Oxidative Stress, and Inflammation,” Tissue & Cell 93 (2025): 102748.

[58] L. Corrêa Costa-Beber, R. Kazmirczak Moraes, J. Marques Obelar Ramos, et al., “Aqueous PM2.5 Promotes Lipid Accumulation, Classical Macrophage Polarisation and Heat Shock Response,” Chemosphere 363 (2024): 142987.

[59] H. Jia, Y. Liu, D. Guo, W. He, L. Zhao, and S. Xia, “PM2 .5-induced Pulmonary Inflammation via Activating of the NLRP3 /Caspase-1 Signaling Pathway,” Environmental Toxicology 36, no. 3 (2021): 298-307.

[60] S. Palleschi, B. Rossi, G. Armiento, et al., “Toxicity of the Readily Leachable Fraction of Urban PM2.5 to human Lung Epithelial Cells: Role of Soluble Metals,” Chemosphere 196 (2018): 35-44.

[61] Y. Xu, Z. Li, Y. Liu, et al., “Differential Roles of Water-Insoluble and Water-Soluble Fractions of Diesel Exhaust Particles in the Development of Adverse Health Effects due to Chronic Instillation of Diesel Exhaust Particles,” Chemical Research in Toxicology 34, no. 12 (2021): 2450-2459.

[62] M. F. Cáceres Quijano, J. De Paula Ribeiro, M. E. Josende, et al., “Assessment of the Effects of Seasonality on the Ecotoxicity Induced by the Particulate Matter Using the Animal Model Caenorhabditis elegans,” Chemosphere 291, no. Pt 2 (2022): 132886.

[63] J. De Paula Ribeiro, A. C. Kalb, S. De Bastos Maya, et al., “The Impact of Polar Fraction of the Fine Particulate Matter on Redox Responses in Different Rat Tissues,” Environmental Science and Pollution Research 26, no. 31 (2019): 32476-32487.

[64] J. D.e P. Ribeiro, A. C. Kalb, P. P. Campos, et al., “Toxicological Effects of Particulate Matter (PM2.5) on Rats: Bioaccumulation, Antioxidant Alterations, Lipid Damage, and ABC Transporter Activity,” Chemosphere 163 (2016): 569-577.

[65] H. Ma , J. Li, C. Wan, et al., “Inflammation Response of Water-Soluble Fractions in Atmospheric Fine Particulates: A Seasonal Observation in 10 Large Chinese Cities,” Environmental Science & Technology 53, no. 7 (2019): 3782-3790.

[66] M. Foksinski, K. Bialkowski, M. Skiba, I. Ponikowska, W. Szmurlo, and R. Olinski, “Evaluation of 8-oxodeoxyguanosine, Typical Oxidative DNA Damage, in Lymphocytes of Ozone-treated Arteriosclerotic Patients,” Mutation Research/Genetic Toxicology and Environmental Mutagenesis 438, no. 1 (1999): 23-27.

[67] X. Hou, Z. Mao, X. Song, et al., “Synergistic Association of Long-term Ozone Exposure and Solid Fuel Use With Biomarkers of Advanced Fibrosis,” Environmental Science and Pollution Research 30, no. 36 (2023): 85318-85329.

[68] M. Celik, M. Koca, Z. Halici, et al., “The Effect of Inhaled Ozone Therapy in Two-Hit Rat Model of Lipopolysaccharides-Induced Acute Lung Injury and Bleomycin-Induced Pulmonary Fibrosis,” The Protein Journal 44, no. 3 (2025): 325-339.

[69] A. Chaiprasongsuk, J. Lohakul, K. Soontrapa, S. Sampattavanich, P. Akarasereenont, and U. Panich, “Activation of Nrf2 Reduces UVA-Mediated MMP-1 Upregulation via MAPK/AP-1 Signaling Cascades: The Photoprotective Effects of Sulforaphane and Hispidulin,” The Journal of Pharmacology and Experimental Therapeutics 360, no. 3 (2017): 388-398.

[70] A. L. Ginzburg , R. S. Blackburn, C. Santillan, L. Truong, R. L. Tanguay, and J. E. Hutchison, “Zinc Oxide-induced Changes to Sunscreen Ingredient Efficacy and Toxicity Under UV Irradiation,” Photochemical & Photobiological Sciences 20, no. 10 (2021): 1273-1285.

[71] N. Lee, K. Youn, J.-H. Yoon, B. Lee, D. H. Kim, and M. Jun, “The Role of Fucoxanthin as a Potent Nrf2 Activator via Akt/GSK-3β/Fyn Axis Against Amyloid-β Peptide-Induced Oxidative Damage,” Antioxidants 12, no. 3 (2023): 629.

[72] J.-W. Zhao, P.-J. Tang, Z.-T. Zhou, et al., “Nrf2 signaling Activation by a Small Molecule Activator Compound 16 Inhibits Hydrogen Peroxide-induced Oxidative Injury and Death in Osteoblasts,” Cell Death Discovery 8, no. 1 (2022): 353.

[73] G. Guan , Y. Chen, and Y. Dong, “Unraveling the AMPK-SIRT1-FOXO Pathway: The in-Depth Analysis and Breakthrough Prospects of Oxidative Stress-Induced Diseases,” Antioxidants (Basel) 14, no. 1 (2025).

[74] J. Song, Z. Li, L. Zhou, et al., “FOXO-regulated OSER1 Reduces Oxidative Stress and Extends Lifespan in Multiple Species,” Nature Communications 15, no. 1 (2024): 7144.

[75] E. S. Gurbuz, Z. Guney, S. Kurgan, N. Balci, M. A. Serdar, and M. Gunhan, “Oxidative Stress and FOXO-1 Relationship in Stage III Periodontitis,” Clinical Oral Investigations 28, no. 5 (2024): 270.

[76] Y. Li, Y. Sun, J. Wang, X. Wang, and W. Yang, “Voacangine Protects Hippocampal Neuronal Cells Against Oxygen-glucose Deprivation/Reoxygenation-Caused Oxidative Stress and Ferroptosis by Activating the PI3K-Akt-FoxO Signaling,” Journal of Applied Toxicology 44, no. 8 (2024): 1246-1256.

[77] Y. Kabe, K. Ando, S. Hirao, M. Yoshida, and H. Handa, “Redox Regulation of NF-kappaB Activation: Distinct Redox Regulation Between the Cytoplasm and the Nucleus,” Antioxidants & Redox Signaling 7, no. 3-4 (2005): 395-403.

[78] S. K. Manna , N. K. Sah, and B. B. Aggarwal, “Protein Tyrosine Kinase p56 Is Required for Ceramide-induced but Not Tumor Necrosis Factor-induced Activation of NF-κB, AP-1, JNK, and Apoptosis,” Journal of Biological Chemistry 275, no. 18 (2000): 13297-13306.

[79] Z. Ren, M. Dharmaratne, H. Liang, et al., “Redox Signalling Regulates Breast Cancer Metastasis via Phenotypic and Metabolic Reprogramming due to p63 Activation by HIF1α,” British Journal of Cancer 130, no. 6 (2024): 908-924.

[80] G. D. Hartman, A. Muniyandi, K. Sishtla, et al., “Ref-1 Redox Activity Regulates Retinal Neovascularization by Modulating Transcriptional Activation of HIF -1α,” The FASEB Journal 39, no. 3 (2025): e70348.

[81] A. R. Bourgonje, D. Kloska, A. Grochot-Przęczek, M. Feelisch, A. Cuadrado, and H. Van Goor, “Personalized Redox Medicine in Inflammatory Bowel Diseases: An Emerging Role for HIF-1α and NRF2 as Therapeutic Targets,” Redox Biology 60 (2023): 102603.

[82] O. M. Ighodaro and O. A. Akinloye, “First Line Defence Antioxidants-superoxide Dismutase (SOD), Catalase (CAT) and Glutathione Peroxidase (GPX): Their Fundamental Role in the Entire Antioxidant Defence Grid,” Alexandria Journal of Medicine 54, no. 4 (2018): 287-293.

[83] K. Jomova, S. Y. Alomar, S. H. Alwasel, E. Nepovimova, K. Kuca, and M. Valko, “Several Lines of Antioxidant Defense Against Oxidative Stress: Antioxidant Enzymes, Nanomaterials With Multiple Enzyme-mimicking Activities, and Low-molecular-weight Antioxidants,” Archives of Toxicology 8, no. 5 (2024): 1323-1367.

[84] L. J. Martin, S. J. Koh, A. Price, D. Park, and B. W. Kim, “Nuclear Localization of Human SOD1 in Motor Neurons in Mouse Model and Patient Amyotrophic Lateral Sclerosis: Possible Links to Cholinergic Phenotype, NADPH Oxidase, Oxidative Stress, and DNA Damage,” International Journal of Molecular Sciences 25, no. 16 (2024): 9106.

[85] A. Dikalova, M. Ao, L. Tkachuk, and S. Dikalov, “Deacetylation Mimetic Mutation of Mitochondrial SOD2 Attenuates ANG II-induced Hypertension by Protecting Against Oxidative Stress and Inflammation,” American Journal of Physiology-Heart and Circulatory Physiology 327, no. 2 (2024): H433-H443.

[86] S. Tamagawa, D. Sakai, H. Nojiri, et al., “SOD2 orchestrates Redox Homeostasis in Intervertebral Discs: A Novel Insight Into Oxidative Stress-mediated Degeneration and Therapeutic Potential,” Redox Biology 71 (2024): 103091.

[87] K. J. Wert, G. Velez, M. R. Cross, et al., “Extracellular Superoxide Dismutase (SOD3) Regulates Oxidative Stress at the Vitreoretinal Interface,” Free Radical Biology and Medicine 124 (2018): 408-419.

[88] Y. Chen, B.o Yuan, Z. Yang, et al., “Catalase-Like Nanozyme-Hybrid Hydrogels Utilizing Endogenous ROS as an Oxygen Source To Synergically Regulate Oxidative Stress and Hypoxia for Enhanced Diabetic Wound Healing,” Biomacromolecules 26, no. 3 (2025): 1672-1685.

[89] J. Guo, F. Li, L. Wang, H. Deng, L. He, and J. Zhao, “Molecular Identification of a Thioredoxin Peroxidase in Babesia gibsoni With Potential Against Oxidative Stress,” Parasitology Research 124, no. 3 (2025): 28.

[90] Y. Y. Li , Y. Xiang, S. Zhang, et al., “Thioredoxin-2 Protects Against Oxygen-glucose Deprivation/Reperfusion Injury by Inhibiting Autophagy and Apoptosis in H9c2 Cardiomyocytes,” American Journal of Translational Research 9, no. 3 (2017): 1471-1482.

[91] X. Hao, M. Liu, X. Zhang, et al., “Thioredoxin-2 Suppresses Hydrogen Peroxide-activated Nuclear Factor Kappa B Signaling via Alleviating Oxidative Stress in Bovine Adipocytes,” Journal of Dairy Science 107, no. 6 (2024): 4045-4055.

[92] S. Toppo, L. Flohé, F. Ursini, S. Vanin, and M. Maiorino, “Catalytic Mechanisms and Specificities of Glutathione Peroxidases: Variations of a Basic Scheme,” Biochimica Et Biophysica Acta (BBA)—General Subjects 1790, no. 11 (2009): 1486-1500.

[93] M. J. Berry, J. D. Kieffer, J. W. Harney, and P. R. Larsen, “Selenocysteine Confers the Biochemical Properties Characteristic of the Type I Iodothyronine Deiodinase,” Journal of Biological Chemistry 266, no. 22 (1991): 14155-14158.

[94] Y. Jiao, Y. Wang, S. Guo, and G. Wang, “Glutathione Peroxidases as Oncotargets,” Oncotarget 8, no. 45 (2017): 80093-80102.

[95] A. P. Kipp , “Selenium-Dependent Glutathione Peroxidases during Tumor Development,” Advances in Cancer Research 136 (2017): 109-138.

[96] X. Xue, Z. Liu, Y. Liang, et al., “Glutathione Peroxidase 4 Suppresses Manganese-dependent Oxidative Stress to Reduce Colorectal Tumorigenesis,” Research Square (2024): rs-3837925. rs.3.

[97] G. Ferguson and W. Bridge, “Glutamate Cysteine Ligase and the Age-related Decline in Cellular Glutathione: The Therapeutic Potential of γ-glutamylcysteine,” Archives of Biochemistry and Biophysics 593 (2016): 12-23.

[98] Y. W. Jun, E. Albarran, D. L. Wilson, J. Ding, and E. T. Kool, “Fluorescence Imaging of Mitochondrial DNA Base Excision Repair Reveals Dynamics of Oxidative Stress Responses,” Angewandte Chemie International Edition 61, no. 6 (2022): e202111829.

[99] B. C. Wysong, P. L. Schuck, M. Sridharan, et al., “Human CST Stimulates Base Excision Repair to Prevent the Accumulation of Oxidative DNA Damage,” Journal of Molecular Biology 436, no. 16 (2024): 168672.

[100] N. Kumar, S. Raja, and B. Van Houten, “The Involvement of Nucleotide Excision Repair Proteins in the Removal of Oxidative DNA Damage,” Nucleic Acids Research 48, no. 20 (2020): 11227-11243.

[101] J. P. Melis, H. van Steeg, and M. Luijten, “Oxidative DNA Damage and Nucleotide Excision Repair,” Antioxidants & Redox Signaling 18, no. 18 (2013): 2409-2419.

[102] Y. Markitantova and V. Simirskii, “Retinal Pigment Epithelium under Oxidative Stress: Chaperoning Autophagy and beyond,” International Journal of Molecular Sciences 26, no. 3 (2025): 1193.

[103] H.-Y. Tian, D.-J. Yu, T. Xie, et al., “Cordycepin Alleviates Metabolic Dysfunction-associated Liver Disease by Restoring Mitochondrial Homeostasis and Reducing Oxidative Stress via Parkin-mediated Mitophagy,” Biochemical Pharmacology 232 (2025): 116750.

[104] R. Kumar and M. S. Jafri, “Computational Modeling of Mitochondria to Understand the Dynamics of Oxidative Stress,” Methods in Molecular Biology 2497 (2022): 363-422.

[105] S. Kumar, V. Chhabra, S. Shenoy, et al., “Role of Flavonoids in Modulation of Mitochondria Dynamics During Oxidative Stress,” Mini-Reviews in Medicinal Chemistry 24, no. 9 (2024): 908-919.

[106] C. Hetz, “The Unfolded Protein Response: Controlling Cell Fate Decisions Under ER Stress and Beyond,” Nature Reviews Molecular Cell Biology 13, no. 2 (2012): 89-102.

[107] X. Zhao, J. Chen, H. Sun, Y. Zhang, and D. Zou, “New Insights Into Fibrosis From the ECM Degradation Perspective: The Macrophage-MMP-ECM Interaction,” Cell & Bioscience 12, no. 1 (2022): 117.

[108] A. M. Fleming and C. J. Burrows, “Why the ROS Matters: One-electron Oxidants Focus DNA Damage and Repair on G-quadruplexes for Gene Regulation,” DNA Repair 145 (2025): 103789.

[109] H. Sies, V. V. Belousov, N. S. Chandel, et al., “Defining Roles of Specific Reactive Oxygen Species (ROS) in Cell Biology and Physiology,” Nature Reviews Molecular Cell Biology 23, no. 7 (2022): 499-515.

[110] B. Halliwell, A. Adhikary, M. Dingfelder, and M. Dizdaroglu, “Hydroxyl Radical Is a Significant Player in Oxidative DNA Damage in Vivo,” Chemical Society Reviews 50, no. 15 (2021): 8355-8360.

[111] E. Illés, A. Mizrahi, V. Marks, and D. Meyerstein, “Carbonate-radical-anions, and Not Hydroxyl Radicals, Are the Products of the Fenton Reaction in Neutral Solutions Containing Bicarbonate,” Free Radical Biology and Medicine 131 (2019): 1-6.

[112] J. A. Imlay, S. M. Chin, and S. Linn, “Toxic DNA Damage by Hydrogen Peroxide Through the Fenton Reaction in Vivo and in Vitro,” Science 240, no. 4852 (1988): 640-642.

[113] M. Giorgio, M. Trinei, E. Migliaccio, and P. G. Pelicci, “Hydrogen Peroxide: A Metabolic by-product or a Common Mediator of Ageing Signals?,” Nature Reviews Molecular Cell Biology 8, no. 9 (2007): 722-728.

[114] P. C. Dedon and S. R. Tannenbaum, “Reactive Nitrogen Species in the Chemical Biology of Inflammation,” Archives of Biochemistry and Biophysics 423, no. 1 (2004): 12-22.

[115] W. L. Neeley and J. M. Essigmann, “Mechanisms of Formation, Genotoxicity, and Mutation of Guanine Oxidation Products,” Chemical Research in Toxicology 19, no. 4 (2006): 491-505.

[116] M. Schieber and N. S. Chandel, “ROS Function in Redox Signaling and Oxidative Stress,” Current Biology 24, no. 10 (2014): R453-R462.

[117] M. M. Gaschler and B. R. Stockwell, “Lipid Peroxidation in Cell Death,” Biochemical and Biophysical Research Communications 482, no. 3 (2017): 419-425.

[118] L. Bertino, F. Guarneri, S. P. Cannavò, M. Casciaro, G. Pioggia, and S. Gangemi, “Oxidative Stress and Atopic Dermatitis,” Antioxidants 9, no. 3 (2020): 196.

[119] N. K. Tonks, “Redox Redux: Revisiting PTPs and the Control of Cell Signaling,” Cell 121, no. 5 (2005): 667-670.

[120] M. Maliougina and Y. El Hiani, “TRPM2: Bridging Calcium and ROS Signaling Pathways—Implications for human Diseases,” Frontiers in Physiology 14 (2023): 1217828.

[121] A. Görlach, K. Bertram, S. Hudecova, and O. Krizanova, “Calcium and ROS: A Mutual Interplay,” Redox Biology 6 (2015): 260-271.

[122] J. W. Denninger and M. A. Marletta, “Guanylate Cyclase and the ⋅NO/cGMP Signaling Pathway,” Biochimica Et Biophysica Acta (BBA)—Bioenergetics 1411, no. 2-3 (1999): 334-350.

[123] S. Owada, Y. Shimoda, K. Tsuchihara, and H. Esumi, “Critical Role of H2O2 Generated by NOX4 During Cellular Response Under Glucose Deprivation,” PLoS ONE 8, no. 3 (2013): e56628.

[124] D. Azzouz, M. A. Khan, N. Sweezey, and N. Palaniyar, “Two-in-one: UV Radiation Simultaneously Induces Apoptosis and NETosis,” Cell Death Discovery 4 (2018): 51.

[125] Y. Chang, Y. He, D.i Wang, et al., “ROS-regulated SUR1-TRPM4 Drives Persistent Activation of NLRP3 Inflammasome in Microglia After Whole-brain Radiation,” Acta Neuropathologica Communications 13, no. 1 (2025): 16.

[126] J. Jin, Y. Zhao, Y. Fang, et al., “Neutrophil Extracellular Traps Promote the Activation of the NLRP3 Inflammasome and PBMCs Pyroptosis via the ROS-dependent Signaling Pathway in Kawasaki Disease,” International Immunopharmacology 145 (2025): 113783.

[127] P. D. Ray, B. W. Huang, and Y. Tsuji, “Reactive Oxygen Species (ROS) Homeostasis and Redox Regulation in Cellular Signaling,” Cellular Signalling 24, no. 5 (2012): 981-990.

[128] H. M. Abu-Soud, O. G. Camp, J. Ramadoss, C. Chatzicharalampous, G. Kofinas, and J. D. Kofinas, “Regulation of Nitric Oxide Generation and Consumption,” International Journal of Biological Sciences 21, no. 3 (2025): 1097-1109.

[129] Y. Jiang, S. Krantz, X. Qin, et al., “Caveolin-1 Controls Mitochondrial Damage and ROS Production by Regulating Fission—fusion Dynamics and Mitophagy,” Redox Biology 52 (2022): 102304.

[130] Z. C. Koc, V. E. Sollars, N. Bou Zgheib, G. O. Rankin, and E. C. Koc, “Evaluation of Mitochondrial Biogenesis and ROS Generation in High-grade Serous Ovarian Cancer,” Frontiers in Oncology 13 (2023): 1129352.

[131] H. Nanjaiah and B. Vallikannan, “Lutein Upregulates the PGC-1α, NRF1, and TFAM Expression by AMPK Activation and Downregulates ROS to Maintain mtDNA Integrity and Mitochondrial Biogenesis in Hyperglycemic ARPE-19 Cells and Rat Retina,” Biotechnology and Applied Biochemistry 66, no. 6 (2019): 999-1009.

[132] L. Sun, N. Ouyang, S. Shafi, et al., “NRF1 Regulates the Epithelial Mesenchymal Transition of Breast Cancer by Modulating ROS Homeostasis,” Technology in Cancer Research & Treatment 22 (2023): 15330338231161141.

[133] L. Kong, S. Li, Y.u Fu, et al., “Mitophagy in Relation to Chronic Inflammation/ROS in Aging,” Molecular and Cellular Biochemistry 480, no. 2 (2025): 721-731.

[134] J. H. Schofield and Z. T. Schafer, “Mitochondrial Reactive Oxygen Species and Mitophagy: A Complex and Nuanced Relationship,” Antioxidants & Redox Signaling 34, no. 7 (2021): 517-530.

[135] C. Vives-Bauza, R. L. A. De Vries, M. Tocilescu, and S. Przedborski, “PINK1/Parkin Direct Mitochondria to Autophagy,” Autophagy 6, no. 2 (2010): 315-316.

[136] A. Gaudioso, P. Garcia-Rozas, M. J. Casarejos, O. Pastor, and J. A. Rodriguez-Navarro, “Lipidomic Alterations in the Mitochondria of Aged Parkin Null Mice Relevant to Autophagy,” Frontiers in Neuroscience 13 (2019): 329.

[137] S. B. Song, S.o-Y. Jang, H. T. Kang, et al., “Modulation of Mitochondrial Membrane Potential and ROS Generation by Nicotinamide in a Manner Independent of SIRT1 and Mitophagy,” Molecules and Cells 40, no. 7 (2017): 503-514.

[138] S. Y. Jang, H. T. Kang, and E. S. Hwang, “Nicotinamide-induced Mitophagy,” Journal of Biological Chemistry 287, no. 23 (2012): 19304-19314.

[139] M. Lu, C. Su, C. Qiao, Y. Bian, J. Ding, and G. Hu, “Metformin Prevents Dopaminergic Neuron Death in MPTP/P-Induced Mouse Model of Parkinson's Disease via Autophagy and Mitochondrial ROS Clearance,” International Journal of Neuropsychopharmacology 19, no. 9 (2016): pyw047.

[140] J.-L. Tu, W.-P. Chen, Z.-J. Cheng, et al., “EGb761 ameliorates Cell Necroptosis by Attenuating RIP1-mediated Mitochondrial Dysfunction and ROS Production in both in Vivo and in Vitro Models of Alzheimer's Disease,” Brain Research 1736 (2020): 146730.

[141] S. Michurina, I. Stafeev, N. Podkuychenko, et al., “Decreased UCP-1 Expression in Beige Adipocytes From Adipose-derived Stem Cells of Type 2 Diabetes Patients Associates With Mitochondrial ROS Accumulation During Obesity,” Diabetes Research and Clinical Practice 169 (2020): 108410.

[142] S.-H. Cha, C. Zhang, S.-J. Heo, and H.-S. Jun, “5-Bromoprotocatechualdehyde Combats Against Palmitate Toxicity by Inhibiting Parkin Degradation and Reducing ROS-Induced Mitochondrial Damage in Pancreatic β-Cells,” Antioxidants 10, no. 2 (2021): 264.

[143] M. T. Coughlan, D. R. Thorburn, S. A. Penfold, et al., “RAGE-induced Cytosolic ROS Promote Mitochondrial Superoxide Generation in Diabetes,” Journal of the American Society of Nephrology 20, no. 4 (2009): 742-752.

[144] J.-P. W. Desforges, C. Sonne, M. Levin, U. Siebert, S. De Guise, and R. Dietz, “Immunotoxic Effects of Environmental Pollutants in Marine Mammals,” Environment International 86 (2016): 126-139.

[145] J. A. Azcona, S. Tang, E. Berry, et al., “Neutrophil-Derived Myeloperoxidase and Hypochlorous Acid Critically Contribute to 20-Hydroxyeicosatetraenoic Acid Increases That Drive Postischemic Angiogenesis,” The Journal of Pharmacology and Experimental Therapeutics 381, no. 3 (2022): 204-216.

[146] M. S. Abdul-Cader, H. Ahmed-Hassan, A. Amarasinghe, E. Nagy, S. Sharif, and M. F. Abdul-Careem, “Toll-Like Receptor (TLR)21 Signalling-mediated Antiviral Response Against Avian Influenza Virus Infection Correlates With Macrophage Recruitment and Nitric Oxide Production,” Journal of General Virology 98, no. 6 (2017): 1209-1223.

[147] A. Dewan, C. Jain, M. Das, et al., “Intracellular Peroxynitrite Perturbs Redox Balance, Bioenergetics, and Fe-S Cluster Homeostasis in Mycobacterium Tuberculosis,” Redox Biology 75 (2024): 103285.

[148] H. Luo, V. Urbonaviciute, A. A. Saei, et al., “NCF1-dependent Production of ROS Protects Against Lupus by Regulating Plasmacytoid Dendritic Cell Development and Functions,” JCI Insight 8, no. 7 (2023): e164875.

[149] A. Christ, S. L. Maas, H. Jin, et al., “In Situ Lipid-loading Activates Peripheral Dendritic Cell Subsets Characterized by Cellular ROS Accumulation but Compromises Their Capacity to Prime Naïve T Cells,” Free Radical Biology and Medicine 210 (2024): 406-415.

[150] R. Shah, B. Ibis, M. Kashyap, and V. A. Boussiotis, “The Role of ROS in Tumor Infiltrating Immune Cells and Cancer Immunotherapy,” Metabolism 151 (2024): 155747.

[151] X. Dai, Y. Fan, and X. Zhao, “Systemic lupus erythematosus: Updated Insights on the Pathogenesis, Diagnosis, Prevention and Therapeutics,” Signal Transduction and Targeted Therapy 10, no. 1 (2025): 102.

[152] C. E. Rockwell, M. Zhang, P. E. Fields, and C. D. Klaassen, “Th2 skewing by Activation of Nrf2 in CD4⁺ T Cells,” The Journal of Immunology 188, no. 4 (2012): 1630-1637.

[153] S. J. Szabo, S. T. Kim, G. L. Costa, X. Zhang, C. G. Fathman, and L. H. Glimcher, “Pillars Article: A Novel Transcription Factor, T-bet, Directs Th1 Lineage Commitment. Cell . 2000. 100: 655-669,” The Journal of Immunology 194, no. 7 (2015): 2961-2975. Cell. 2000. 100: 655-669.

[154] T. Abimannan, D. Peroumal, J. R. Parida, P. K. Barik, P. Padhan, and S. Devadas, “Oxidative Stress Modulates the Cytokine Response of Differentiated Th17 and Th1 Cells,” Free Radical Biology and Medicine 99 (2016): 352-363.

[155] G. Fu, Q. Xu, Y. Qiu, et al., “Suppression of Th17 Cell Differentiation by Misshapen/NIK-related Kinase MINK1,” Journal of Experimental Medicine 214, no. 5 (2017): 1453-1469.

[156] X. Yu, Y. Lao, X.-L.u Teng, et al., “SENP3 maintains the Stability and Function of Regulatory T Cells via BACH2 deSUMOylation,” Nature Communications 9, no. 1 (2018): 3157.

[157] H.-R. Kim, A. Lee, E.-J. Choi, et al., “Reactive Oxygen Species Prevent Imiquimod-induced Psoriatic Dermatitis Through Enhancing Regulatory T Cell Function,” PLoS ONE 9, no. 3 (2014): e91146.

[158] T. W. Mak, M. Grusdat, G. S. Duncan, et al., “Glutathione Primes T Cell Metabolism for Inflammation,” Immunity 46, no. 6 (2017): 1089-1090.

[159] Y.-Y. Feng, M. Tang, M. Suzuki, et al., “Essential Role of NADPH Oxidase-Dependent Production of Reactive Oxygen Species in Maintenance of Sustained B Cell Receptor Signaling and B Cell Proliferation,” The Journal of Immunology 202, no. 9 (2019): 2546-2557.

[160] R. Vene, L. Delfino, P. Castellani, et al., “Redox Remodeling Allows and Controls B-cell Activation and Differentiation,” Antioxidants & Redox Signaling 13, no. 8 (2010): 1145-1155.

[161] D. Hanahan, “Hallmarks of Cancer: New Dimensions,” Cancer Discovery 12, no. 1 (2022): 31-46.

[162] X. Tong, X. Zhu, X. Wang, et al., “Oxidative Stress-Related KEAP1 and NRF2 Genes Contributed to the Risk of Epithelial Ovarian Cancer,” Biochemical Genetics (2025).

[163] R. Dong, J. Wang, R. Guan, J. Sun, P. Jin, and J. Shen, “Role of Oxidative Stress in the Occurrence, Development, and Treatment of Breast Cancer,” Antioxidants 14, no. 1 (2025): 104.

[164] W. Li, L. Shen, Q. Yang, Q. Zhang, Y. Cao, and T. Liu, “Oxidative Stress Index-based Scoring for Prediction of Long-term Prognosis in Patients With Colorectal Cancer With Liver Metastases,” Scientific Reports 15, no. 1 (2025): 5253.

[165] C. K. Chan, Y. L. Tsai, and M. Y. Chang, “Construction of Nitrated Benzo[3.3.1]Bicyclic Acetal/Ketal Core via Nitration of o-Carbonyl Allylbenzenes,” Organic Letters 19 (2017): 1358-1361.

[166] S.-C. Wang, M.-Y. Chang, J.-P. Shiau, et al., “Antiproliferation- and Apoptosis-Inducible Effects of a Novel Nitrated [6,6,6]Tricycle Derivative (SK2) on Oral Cancer Cells,” Molecules (Basel, Switzerland) 27, no. 5 (2022): 1576.

[167] K.-H. Yang, C.-Y.u Yen, S.-C. Wang, et al., “6-n-Butoxy-10-nitro-12,13-dioxa-11-azatricyclo[7.3.1.0^2,7]Trideca-2,4,6,10-tetraene Improves the X-ray Sensitivity on Inhibiting Proliferation and Promoting Oxidative Stress and Apoptosis of Oral Cancer Cells,” Biomedicines 12, no. 2 (2024): 458.

[168] Z. Li, Q. Liu, G. Wang, et al., “An Oxidative Stress Nanoamplifier to Enhance the Efficacy of Cisplatin in Head and Neck Cancer,” Angewandte Chemie International Edition in English (2025): e202421481.

[169] H. Han, G. Zhang, Y. Yang, et al., “Therapeutic Potential of Monomethyl Fumarate and Aluminum Ion Combination in Alleviating Inflammation and Oxidative Stress in Psoriasis,” Redox Biology 79 (2025): 103482.

[170] B. Beksac, E. Adisen, and M. A. Gurer, “Treatment of Generalized Pustular Psoriasis of Pregnancy with Infliximab,” Cutis; Cutaneous Medicine for the Practitioner 107, no. 3 (2021): E2-E5.

[171] J. Zhang, P. Xia, L.i Wan, L. Chen, X. Zhou, and J. Chen, “Generalized Pustular Psoriasis of Pregnancy Successfully Treated With secukinumab,” Indian Journal of Dermatology, Venereology and Leprology 89, no. 6 (2023): 886-888.

[172] F. Bellelli, D. Angioni, B. Arosio, B. Vellas, and P. De Souto Barreto, “Hallmarks of Aging and Alzheimer's Disease Pathogenesis: Paving the Route for New Therapeutic Targets,” Ageing Research Reviews 106 (2025): 102699.

[173] K. Hirai, G. Aliev, A. Nunomura, et al., “Mitochondrial Abnormalities in Alzheimer's Disease,” The Journal of Neuroscience 21, no. 9 (2001): 3017-3023.

[174] M. R. Christensen, H. E. Poulsen, T. Henriksen, et al., “Elevated Levels of 8-oxoGuo and 8-oxodG in Individuals With Severe Mental Illness—An Autopsy-based Study,” Free Radical Biology and Medicine 126 (2018): 372-378.

[175] Y. Tang, L.i Meng, C.-M. Wan, et al., “Identifying the Presence of Parkinson's Disease Using Low-frequency Fluctuations in BOLD Signals,” Neuroscience Letters 645 (2017): 1-6.

[176] J. Wang, M. Liu, J. Zhao, et al., “Oxidative Stress and Dysregulated Long Noncoding RNAs in the Pathogenesis of Parkinson's Disease,” Biological Research 58, no. 1 (2025): 7.

[177] P. Risiglione, F. Zinghirino, M. C. Di Rosa, A. Magrì, and A. Messina, “Alpha-Synuclein and Mitochondrial Dysfunction in Parkinson's Disease: The Emerging Role of VDAC,” Biomolecules 11, no. 5 (2021): 718.

[178] K. Zhai, B. Liu, and L. Gao, “Long-Noncoding RNA TUG1 Promotes Parkinson's Disease via Modulating MiR-152-3p/PTEN Pathway,” Human Gene Therapy 31 (2020): 1274-1287. 23-24.

[179] Q. Song, Y. Geng, Y. Li, L. Wang, and J. Qin, “Long Noncoding RNA NORAD Regulates MPP+-induced Parkinson's Disease Model Cells,” Journal of Chemical Neuroanatomy 101 (2019): 101668.

[180] J. Fernández-Torres, K. Martínez-Flores, I. X. Puerta-Escalante, et al., “Interplay of Calcium Pyrophosphate Crystals, Oxidative Stress, and Clinical Features on Knee Osteoarthritis Severity,” Clinical Rheumatology 44, no. 1 (2025): 433-441.

[181] X. Yang, J. Wang, C. Wei, J. Tian, L. Yan, and Q. Huang, “Association Between Ethylene Oxide Exposure and Osteoarthritis Risk Mediated by Oxidative Stress: Evidence From NHANES 2013-2020,” Medical Gas Research 15, no. 2 (2025): 348-355.

[182] M. Aydin, G. Alp Avci, U. I. Yilmaz, T. Aydin, and E. Avci, “Evaluation of Oxidative Stress and Cellular Immunity in Grades III-IV Knee Osteoarthritis,” Archives of Bone and Joint Surgery 12, no. 12 (2024): 840-845.

[183] K. Hemati, M. H. Pourhanifeh, I. Fatemi, A. Hosseinzadeh, and S. Mehrzadi, “Anti-Degenerative Effect of Melatonin on Intervertebral Disc: Protective Contribution Against Inflammation, Oxidative Stress, Apoptosis, and Autophagy,” Current Drug Targets 23, no. 7 (2022): 711-718.

[184] Z. Zhu, Z. Huang, C. Zhang, et al., “Gallic Acid Protects Intervertebral Disc Cells From Ferroptosis and Alleviates Intervertebral Disc Degeneration by Regulating Key Factors of Oxidative Stress,” Frontiers in Pharmacology 16 (2025): 1501725.

[185] Z. Guo, X. Wang, J. Sun, et al., “Injectable Nanocomposite Hydrogels for Intervertebral Disc Degeneration: Combating Oxidative Stress, Mitochondrial Dysfunction, and Ferroptosis,” Advanced Healthcare Materials (2025): e2403892.

[186] Y. Yang and M. Dong, “Exploring the Role of Oxidative Stress in Carotid Atherosclerosis: Insights From Transcriptomic Data and Single-cell Sequencing Combined With Machine Learning,” Biology Direct 20, no. 1 (2025): 15.

[187] H. Li, B. Ye, J. Tian, et al., “Monotropein Resists Atherosclerosis by Reducing Inflammation, Oxidative Stress, and Abnormal Proliferation and Migration of Vascular Smooth Muscle Cells,” The Korean Journal of Physiology & Pharmacology 29, no. 2 (2025): 245-255.

[188] P. Fountoulakis, I. Kourampi, P. Theofilis, et al., “Oxidative Stress Biomarkers in Hypertension,” Current Medicinal Chemistry (2025): 8765-8782.

[189] X. Lin, J. Zhao, S. Ge, et al., “Dietary Polyphenol Intake and Risk of Hypertension: An 18-y Nationwide Cohort Study in China,” The American Journal of Clinical Nutrition 118, no. 1 (2023): 264-272.

[190] J. Luan, M. Yu, Q.i Gu, et al., “Fatty Acid Synthase Inhibition Improves Hypertension-induced Erectile Dysfunction by Suppressing Oxidative Stress and NLRP3 Inflammasome-dependent Pyroptosis Through Activating the Nrf2/HO-1 Pathway,” Frontiers in Immunology 15 (2024): 1532021.

[191] M. A. Zaafan and A. M. Abdelhamid, “Molecular Insight of miRNA-217 Role in the Pathogenesis of Myocardial Infarction: Promising Diagnostic Biomarker and Therapeutic Target,” Non-coding RNA Research 10 (2025): 192-197.

[192] J. Liu, Y. Li, S. Wu, Z. Zhang, and D.i Li, “Hyperbaric Oxygen Upregulates Mst1 to Activate Keap1/Nrf2/HO-1 Pathway Resisting Oxidative Stress in a Rat Model of Acute Myocardial Infarction,” Molecular Biotechnology 67, no. 1 (2025): 284-293.

[193] J. Wang, N. Wu, J. Zhang, et al., “Ciliary Neurotrophic Factor Attenuates Myocardial Infarction-induced Oxidative Stress and Ferroptosis via PI3K/Akt Signaling,” Journal of Molecular Histology 56, no. 2 (2025): 90.

[194] L. L. Armando, L. R. Julián de Jesús, L. O. Raúl, S. M. Roberto, R. C. Óscar, and K. Mina, “Biomarkers of Oxidative Stress, Inflammation, and Brain Damage in Mexican Women Over 60 Years of Age With Obesity,” Revista De Investigacion Clinica-Clinical and Translational Investigation 77, no. 1 (2025): 13-25.

[195] L. F. N. De Oliveira, C. S. C. Maia, M. D. D.e A. Nogueira, et al., “Cashew Nut Consumption Reduces Waist Circumference and Oxidative Stress in Adolescents With Obesity: A Randomized Clinical Trial,” Nutrition Research 134 (2025): 60-72.

[196] I. T. Suryaningtyas, C. K. Marasinghe, B. Lee, and J.-Y. Je, “Oral Administration of PIISVYWK and FSVVPSPK Peptides Attenuates Obesity, Oxidative Stress, and Inflammation in High Fat Diet-induced Obese Mice,” The Journal of Nutritional Biochemistry 136 (2025): 109791.

[197] A. Caturano, M. Rocco, G. Tagliaferri, et al., “Oxidative Stress and Cardiovascular Complications in Type 2 Diabetes: From Pathophysiology to Lifestyle Modifications,” Antioxidants 14, no. 1 (2025): 72.

[198] I. Brodyak, A. Moroz, K. Bernacka, A. Z. Kucharska, and N. Sybirna, “Alleviation of Hyperglycaemia and Oxidative Stress by Fruit Extracts of Different Cultivars of the cornelian Cherry (Cornus mas L. and Cornus mas x Cornus officinalis) in Rats With Diabetes Mellitus,” Food & Function 16, no. 5 (2025): 2136-2155.

[199] Y. Zhang, Y. Ye, X. Jia, P. Wang, Z. Xiong, and H. Zhu, “The Protective Effects of Salusin-alpha Against Oxidative Stress and Inflammatory Response in Mice With Gestational Diabetes Mellitus (GDM),” Archives of Physiology and Biochemistry (2025): 1-10.

[200] P. Zhu, Y. Jin, J. Sun, and X. Zhou, “The Efficacy of Resveratrol Supplementation on Inflammation and Oxidative Stress in Type-2 Diabetes Mellitus Patients: Randomized Double-blind Placebo Meta-analysis,” Frontiers in Endocrinology 15 (2024): 1463027.

[201] S. Zhuang, J. Fu, L. Wu, X. Xu, and C. Guo, “Role of USF1 in Activating CYBA Transcription and Influencing NADPH-ROS-mediated Oxidative Stress and Lipid Accumulation in Non-alcoholic Fatty Liver Disease,” Biochimica Et Biophysica Acta (BBA)—Molecular and Cell Biology of Lipids 1870, no. 2 (2025): 159581.

[202] S. Mohammed, E. H. Nicklas, N. Thadathil, et al., “Role of Necroptosis in Chronic Hepatic Inflammation and Fibrosis in a Mouse Model of Increased Oxidative Stress,” Free Radical Biology and Medicine 164 (2021): 315-328.

[203] S. Mighani, R. Samimi, M. R. Nooshabadi, S. A. Farzam, H. K. Haghighian, and M. Javadi, “A Randomized Double-blind Clinical Trial Investigating the Effects of Ellagic Acid on Glycemic Status, Liver Enzymes, and Oxidative Stress in Patients With Non-alcoholic Fatty Liver Disease,” BMC Complementary Medicine and Therapies 25, no. 1 (2025): 33.

[204] K. A. Dias, L. A. Oliveira, S. M. S. Pereira, et al., “Anti-inflammatory and Antioxidant Effects of Anthocyanins in Nonalcoholic Fatty Liver Disease (NAFLD): A Systematic Review of in Vivo Studies,” Critical Reviews in Food Science and Nutrition (2025): 1-18.

[205] Y. Fu, C. Jiang, Z. Li, X. Shi, P. Lv, and J. Zhang, “Association Between the Composite Dietary Antioxidant Index and Non-alcoholic Fatty Liver Disease: Evidence From National Health and Nutrition Examination Survey 2005-2016,” Frontiers in Nutrition 12 (2025): 1473487.

[206] M. Ge, T. Papagiannakopoulos, and L. Bar-Peled, “Reductive Stress in Cancer: Coming out of the Shadows,” Trends in Cancer 10, no. 2 (2024): 103-112.

[207] L. Kennedy, J. K. Sandhu, M.-E. Harper, and M. Cuperlovic-Culf, “Role of Glutathione in Cancer: From Mechanisms to Therapies,” Biomolecules 10, no. 10 (2020): 1429.

[208] R. Romero, V. I. Sayin, S. M. Davidson, et al., “Keap1 loss Promotes Kras-driven Lung Cancer and Results in Dependence on Glutaminolysis,” Nature Medicine 23, no. 11 (2017): 1362-1368.

[209] X. Gao, K. Wei, B.o Hu, K. Xu, and B.o Tang, “Ascorbic Acid Induced HepG2 Cells' apoptosis via Intracellular Reductive Stress,” Theranostics 9, no. 14 (2019): 4233-4240.

[210] V. Ahire, A. Kumar, K. P. Mishra, and G. Kulkarni, “Ellagic Acid Enhances Apoptotic Sensitivity of Breast Cancer Cells to γ-Radiation,” Nutrition and Cancer 69, no. 6 (2017): 904-910.

[211] A. Lloret, T. Fuchsberger, E. Giraldo, and J. Vina, “Reductive Stress: A New Concept in Alzheimer's Disease,” Current Alzheimer Research 13, no. 2 (2016): 206-211.

[212] V. Ostwal, A. Ramaswamy, P. Bhargava, et al., “A Pro-oxidant Combination of Resveratrol and Copper Reduces Chemotherapy-related Non-haematological Toxicities in Advanced Gastric Cancer: Results of a Prospective Open Label Phase II Single-arm Study (RESCU III study),” Medical Oncology 40, no. 1 (2022): 17.

[213] E. J. Hong, P. Sivakumar, V. Ravichandran, D. G. Choi, Y. S. Kim, and M. S. Shim, “Pro-Oxidant Drug-Loaded Au/ZnO Hybrid Nanoparticles for Cancer-Specific Chemo-Photodynamic Combination Therapy,” ACS Biomaterials Science & Engineering 5, no. 10 (2019): 5209-5217.

[214] S. J. Ralph, S. Nozuhur, R. A. Alhulais, S. Rodríguez-Enríquez, and R. Moreno-Sánchez, “Repurposing Drugs as Pro-Oxidant Redox Modifiers to Eliminate Cancer Stem Cells and Improve the Treatment of Advanced Stage Cancers,” Medicinal Research Reviews 39, no. 6 (2019): 2397-2426.

[215] N. Sassi, A. Mattarei, V. Espina, et al., “Potential Anti-cancer Activity of 7-O-pentyl Quercetin: Efficient, Membrane-targeted Kinase Inhibition and Pro-oxidant Effect,” Pharmacological Research 124 (2017): 9-19.

[216] X. Zhang, T. Zhu, Y. Miao, L.u Zhou, and W. Zhang, “Dual-responsive Doxorubicin-loaded Nanomicelles for Enhanced Cancer Therapy,” Journal of Nanobiotechnology 18, no. 1 (2020): 136.

[217] J. Xie, Z. Lai, X. Zheng, et al., “Apoptotic Activities of brusatol in human Non-small Cell Lung Cancer Cells: Involvement of ROS-mediated Mitochondrial-dependent Pathway and Inhibition of Nrf2-mediated Antioxidant Response,” Toxicology 451 (2021): 152680.

[218] X.i Yu, Z. He, Z. Wang, et al., “Brusatol Hinders the Progression of Bladder Cancer by Chac1/Nrf2/SLC7A11 Pathway,” Experimental Cell Research 438, no. 2 (2024): 114053.

[219] Z. Gong, L. Xue, A. C. Vlantis, et al., “Brusatol Attenuated Proliferation and Invasion Induced by KRAS in Differentiated Thyroid Cancer Through Inhibiting Nrf2,” Journal of Endocrinological Investigation 47, no. 5 (2024): 1271-1280.

[220] Y. Xiang, W. Ye, C. Huang, et al., “Brusatol Enhances the Chemotherapy Efficacy of Gemcitabine in Pancreatic Cancer via the Nrf2 Signalling Pathway,” Oxidative Medicine and Cellular Longevity 2018 (2018): 2360427.

[221] M. Hu, D.i Sun, J. Yu, et al., “Brusatol Sensitizes Endometrial Hyperplasia and Cancer to Progestin by Suppressing NRF2-TET1-AKR1C1-mediated Progestin Metabolism,” Laboratory Investigation 102, no. 12 (2022): 1335-1345.

[222] S. Yuan, C. Wei, G. Liu, et al., “Sorafenib Attenuates Liver Fibrosis by Triggering Hepatic Stellate Cell Ferroptosis via HIF-1α/SLC7A11 Pathway,” Cell Proliferation 55, no. 1 (2022): e13158.

[223] M. A. Abou Taha, F. E. M. Ali, I. G. Saleh, and E.l-S. Akool, “Sorafenib and edaravone Protect Against Renal Fibrosis Induced by Unilateral Ureteral Obstruction via Inhibition of Oxidative Stress, Inflammation, and RIPK-3/MLKL Pathway,” Naunyn-Schmiedeberg's Archives of Pharmacology 397, no. 11 (2024): 8961-8977.

[224] H. T. Tran, L. B. Vong, Y. Nishikawa, and Y. Nagasaki, “Sorafenib-loaded Silica-containing Redox Nanoparticles for Oral Anti-liver Fibrosis Therapy,” Journal of Controlled Release 345 (2022): 880-891.

[225] P. Wang, R. Zhou, R. Zhou, et al., “Epidermal Growth Factor Potentiates EGFR(Y992/1173)-mediated Therapeutic Response of Triple Negative Breast Cancer Cells to Cold Atmospheric Plasma-activated Medium,” Redox Biology 69 (2024): 102976.

[226] X. Dai, Z. Xu, X. Lv, et al., “Cold Atmospheric Plasma Potentiates Ferroptosis via EGFR(Y1068)-mediated Dual Axes on GPX4 Among Triple Negative Breast Cancer Cells,” International Journal of Biological Sciences 21, no. 2 (2025): 874-892.

[227] X. Dai, D. Cai, P. Wang, et al., “Cold Atmospheric Plasmas Target Breast Cancer Stemness via Modulating AQP3-19Y Mediated AQP3-5K and FOXO1 K48-ubiquitination,” International Journal of Biological Sciences 18, no. 8 (2022): 3544-3561.

[228] P. Wang, R. Zhou, P. Thomas, et al., “Epithelial-to-Mesenchymal Transition Enhances Cancer Cell Sensitivity to Cytotoxic Effects of Cold Atmospheric Plasmas in Breast and Bladder Cancer Systems,” Cancers 13, no. 12 (2021): 2889.

[229] L. Miebach, H. Mohamed, K. Wende, V. Miller, and S. Bekeschus, “Pancreatic Cancer Cells Undergo Immunogenic Cell Death Upon Exposure to Gas Plasma-Oxidized Ringers Lactate,” Cancers 15, no. 1 (2023): 319.

[230] K. Zhu, Q. Lv, X. Lu, Y. Wang, and X. Dai, “Cold Atmospheric Plasma Restores Skewed Macrophage Polarization in Triple Negative Breast Cancers via Enhancing KAT6A Acetylation,” Free Radical Biology and Medicine 226 (2025): 364-373.

[231] X. Dai and K. Zhu, “Cold Atmospheric Plasma: Novel Opportunities for Tumor Microenvironment Targeting,” Cancer Medicine 12, no. 6 (2023): 7189-7206.

[232] L. Miebach, E. Freund, R. Clemen, S. Kersting, L.-I. Partecke, and S. Bekeschus, “Gas Plasma-oxidized Sodium Chloride Acts via Hydrogen Peroxide in a Model of Peritoneal Carcinomatosis,” Proceedings of the National Academy of Sciences of the United States of America 119, no. 31 (2022): e2200708119.

[233] L. Miebach, E. Freund, S. Horn, et al., “Tumor Cytotoxicity and Immunogenicity of a Novel V-jet Neon Plasma Source Compared to the kINPen,” Scientific Reports 11, no. 1 (2021): 136.

[234] S. PR, S. K, and S. Y, “Cold Atmospheric Plasma-induced Oxidative Stress and Ensuing Immunological Response—a Neo-Vista in Immunotherapy,” Free Radical Research 56, no. 7-8 (2022): 498-510.

[235] X. Dai, J. Li, Y. Chen, and K. (.K.). Ostrikov, “When Onco-Immunotherapy Meets Cold Atmospheric Plasma: Implications on CAR-T Therapies,” Frontiers in Oncology 12 (2022): 837995.

[236] G. Chen, Z. Chen, D.i Wen, et al., “Transdermal Cold Atmospheric Plasma-mediated Immune Checkpoint Blockade Therapy,” Proceedings of the National Academy of Sciences of the United States of America 117, no. 7 (2020): 3687-3692.

[237] N. D. Almeida, A. L. Klein, E. A. Hogan, et al., “Cold Atmospheric Plasma as an Adjunct to Immunotherapy for Glioblastoma Multiforme,” World Neurosurgery 130 (2019): 369-376.

[238] V. Soni, M. Adhikari, L.i Lin, J. H. Sherman, and M. Keidar, “Theranostic Potential of Adaptive Cold Atmospheric Plasma With Temozolomide to Checkmate Glioblastoma: An in Vitro Study,” Cancers 14, no. 13 (2022): 3116.

[239] K.-R. Liedtke, E. Freund, M. Hermes, et al., “Gas Plasma-Conditioned Ringer's Lactate Enhances the Cytotoxic Activity of Cisplatin and Gemcitabine in Pancreatic Cancer in Vitro and in Ovo,” Cancers 12, no. 1 (2020): 123.

[240] X. Dai, S. Feng, and Y. Zheng, “Cold Atmospheric Plasma: Possible Cure of Autoimmune Disorders and Cancer via Attenuating Inflammation,” International Journal of Biological Sciences 20, no. 14 (2024): 5436-5449.

[241] Y.u-J. Kim, B. J. Kim, J. Seok, H. S. Han, K. H. o Yoo, and S. Y. Choi, “Cold Plasma Ameliorates Imiquimod-Induced Psoriasis-like Skin Inflammation in Mice,” Skin Research and Technology 30, no. 10 (2024): e70071.

[242] C. Gareri, L. Bennardo, and G. De Masi, “Use of a New Cold Plasma Tool for Psoriasis Treatment: A Case Report,” SAGE Open Medical Case Reports 8 (2020): 2050313×20922709.

[243] L. Zheng, J. Gao, Y. Cao, et al., “Two Case Reports of Inverse Psoriasis Treated With Cold Atmospheric Plasma,” Dermatologic Therapy 33, no. 6 (2020): e14257.

[244] A. Suwanchinda and T. Nararatwanchai, “Efficacy and Safety of the Innovative Cold Atmospheric-Pressure Plasma Technology in the Treatment of Keloid: A Randomized Controlled Trial,” Journal of Cosmetic Dermatology 21, no. 12 (2022): 6788-6797.

[245] N.a Wang, T. Yan, X. Mei, J. Liu, Y. Lei, and C. Yang, “Cold Atmospheric Plasma Therapy for Malassezia Folliculitis: Laboratory Investigations and a Randomized Clinical Trial,” Skin Research and Technology 30, no. 7 (2024): e13850.

[246] J. Wang, K.e Xue, J. Gao, et al., “Efficacy and Safety of Cold Atmospheric Plasma-Assisted Therapy for Herpes Zoster: A Randomized, Parallel, Positive-Controlled, Non-inferiority Multicenter Clinical Trial,” Dermatology and Therapy 15, no. 9 (2025): 2391-2408.

[247] Z. Paknahad, E. Sheklabadi, A. R. Moravejolahkami, A. Chitsaz, and A. Hassanzadeh, “The Effects of Mediterranean Diet on Severity of Disease and Serum Total Antioxidant Capacity (TAC) in Patients With Parkinson's Disease: A Single Center, Randomized Controlled Trial,” Nutritional Neuroscience 25, no. 2 (2022): 313-320.

[248] C. Bekar, B. Armagan, A. Sari, and A. Ayaz, “Evaluation of Serum Total Antioxidant Level, Nutritional Status and Mediterranean Diet Adherence of Adult Women With Rheumatoid Arthritis: A Case-control Study,” British Journal of Nutrition 133, no. 2 (2025): 239-245.

[249] M. M. Quetglas-Llabrés, M. Monserrat-Mesquida, C. Bouzas, et al., “Impact of Adherence to the Mediterranean Diet on Antioxidant Status and Metabolic Parameters in NAFLD Patients: A 24-Month Lifestyle Intervention Study,” Antioxidants 13, no. 4 (2024): 480.

[250] M. J. Sánchez-Quintero, J. Delgado, L. Martín Chaves, et al., “Multi-Omics Approach Reveals Prebiotic and Potential Antioxidant Effects of Essential Oils From the Mediterranean Diet on Cardiometabolic Disorder Using Humanized Gnotobiotic Mice,” Antioxidants 12, no. 8 (2023): 1643.

[251] M. Böhm, M. Parekh, N. Deshpande, et al., “Mitochondria-Targeted Antioxidant (MitoQ) and Nontargeted Antioxidant (Idebenone) Mitigate Mitochondrial Dysfunction in Corneal Endothelial Cells,” Cornea 44, no. 4 (2025): 492-503.

[252] S. Peshkar-Kulkarni, D. D. Chung, and A. J. Aldave, “Antioxidant MitoQ Increases Viability of human Corneal Endothelial Cells With Congenital Hereditary Endothelial Dystrophy-associated SLC4A11 Mutations,” Ophthalmic Genetics (2025): 1-8.

[253] L. Hocum Stone, E. Chappuis, C. Wright, R. F. Kelly, and E. O. McFalls, “CoQ(10) Enhances PGC1alpha and Increases Expression of Mitochondrial Antioxidant Proteins in Chronically Ischemic Swine Myocardium,” Nutrition & Metabolism (London) 16 (2019): 92.

[254] W. Zhang, X. Wang, X. Li, et al., “Effects of Acute Moderate-intensity Aerobic Exercise on Cognitive Function in E-athletes: A Randomized Controlled Trial,” Medicine 102, no. 40 (2023): e35108.

[255] R. K. Kalapatapu and K. L. Delucchi, “APOE e4 Genotype and Cigarette Smoking in Adults With Normal Cognition and Mild Cognitive Impairment: A Retrospective Baseline Analysis of a National Dataset,” The American Journal of Drug and Alcohol Abuse 39, no. 4 (2013): 219-226.

[256] E. Ringin, V. Cropley, A. Zalesky, et al., “The Impact of Smoking Status on Cognition and Brain Morphology in Schizophrenia Spectrum Disorders,” Psychological Medicine 52, no. 14 (2022): 3097-3115.

[257] H. Essa, H. M. Ali, P. H. Min, et al., “Impact of Alcohol Use Disorder on Cognition in Correlation With Aging: A Community-based Retrospective Cohort Study,” Alcohol and Alcoholism 60, no. 1 (2024): agae080.

[258] B. A. Gimbel, J. R. Wozniak, B. A. Mueller, et al., “Regional Hippocampal Thinning and Gyrification Abnormalities and Associated Cognition in Children With Prenatal Alcohol Exposure,” Journal of Neurodevelopmental Disorders 17, no. 1 (2025): 5.

[259] G. H. Vu and H. D. Nguyen, “Molecular Mechanisms of Sulforaphane in Alzheimer's Disease: Insights From an in-silico Study,” In Silico Pharmacology 12, no. 2 (2024): 96.

[260] W. U. Khan, M. Salman, M. Ali, et al., “Neuroprotective Effects of Sulforaphane in a Rat Model of Alzheimer's Disease Induced by Aβ (1-42) Peptides,” Neurochemistry International 179 (2024): 105839.

[261] J. Kim, “Pre-Clinical Neuroprotective Evidences and Plausible Mechanisms of Sulforaphane in Alzheimer's Disease,” International Journal of Molecular Sciences 22, no. 6 (2021): 2929.

[262] F. Morroni, G. Sita, A. Djemil, et al., “Comparison of Adaptive Neuroprotective Mechanisms of Sulforaphane and Its Interconversion Product Erucin in in Vitro and in Vivo Models of Parkinson's Disease,” Journal of Agricultural and Food Chemistry 66, no. 4 (2018): 856-865.

[263] F. Morroni, A. Tarozzi, G. Sita, et al., “Neuroprotective Effect of Sulforaphane in 6-hydroxydopamine-lesioned Mouse Model of Parkinson's disease,” Neurotoxicology 36 (2013): 63-71.

[264] A. Huang, Z. Wang, H. Tang, et al., “Bardoxolone Methyl Ameliorates Myocardial Ischemia/Reperfusion Injury by Activating the Nrf2/HO-1 Signaling Pathway,” Cardiovascular Therapeutics 2023 (2023): 1-12.

[265] A. K. Kalvala, R. Kumar, B. Sherkhane, C. Gundu, V. K. Arruri, and A. Kumar, “Bardoxolone Methyl Ameliorates Hyperglycemia Induced Mitochondrial Dysfunction by Activating the keap1-Nrf2-ARE Pathway in Experimental Diabetic Neuropathy,” Molecular Neurobiology 57, no. 8 (2020): 3616-3631.

[266] J.-L. Yang, M.-Y. Sun, Q.i Yuan, et al., “Keap1-Nrf2 signaling Activation by Bardoxolone-methyl Ameliorates High Glucose-induced Oxidative Injury in human Umbilical Vein Endothelial Cells,” Aging 12, no. 11 (2020): 10370-10380.

[267] A. Kuno, R. Hosoda, Y. Saga, et al., “Resveratrol Promotes Autophagosome Elimination via SIRT1 in Cardiomyocytes,” Journal of Pharmacological Sciences 157, no. 1 (2025): 25-34.

[268] L. Zhu, M. Yang, L. Fan, et al., “Interaction Between Resveratrol and SIRT1: Role in Neurodegenerative Diseases,” Naunyn-Schmiedeberg's Archives of Pharmacology 398, no. 1 (2025): 89-101.

[269] B. Rogina and H. A. Tissenbaum, “SIRT1, resveratrol and Aging,” Frontiers in Genetics 15 (2024): 1393181.

[270] F. Ni, F. Wang, J. Li, et al., “BNC1 deficiency Induces Mitochondrial Dysfunction-triggered Spermatogonia Apoptosis Through the CREB/SIRT1/FOXO3 Pathway: The Therapeutic Potential of Nicotinamide Riboside and Metformin,” Biology of Reproduction 110, no. 3 (2024): 615-631.

[271] L. Hu, Y. Guo, L. Song, et al., “Nicotinamide Riboside Promotes Mfn2-mediated Mitochondrial Fusion in Diabetic Hearts Through the SIRT1-PGC1α-PPARα Pathway,” Free Radical Biology and Medicine 183 (2022): 75-88.

[272] F. Faramarzi, P. Zafari, M. Alimohammadi, M. Golpour, S. Ghaffari, and A. Rafiei, “Inhibitory Effects of Cold Atmospheric Plasma on Inflammation and Tumor-Like Feature of Fibroblast-Like Synoviocytes From Patients With Rheumatoid Arthritis,” Inflammation 45, no. 6 (2022): 2433-2448.

[273] L. Y. Ni, C. B. Ding, J. M. Deng, Z. W. Wu, and Y. Zhou, “Cold Air Plasma Inhibiting Tumor-Like Biological Behavior of Rheumatoid Arthritis Fibroblast-Like Synovial Cells via G2/M Cell Cycle Arrest,” Open Access Rheumatology 16 (2024): 75-85.

[274] C. Ding, L. Ni, Q. Liu, et al., “Cold Air Plasma Improving Rheumatoid Arthritis via Mitochondrial Apoptosis Pathway,” Bioengineering & Translational Medicine 8, no. 1 (2023): e10366.

[275] C. Ding, Q.i Liu, W. Ouyang, et al., “Cold Atmospheric Pressure Plasma: A Potential Physical Therapy for Rheumatoid Arthritis Hyperplastic Synovium,” International Immunopharmacology 123 (2023): 110732.

[276] D. L. Juarez-Flores, M. Ezquerra, Ï. Gonzàlez-Casacuberta, et al., “Disrupted Mitochondrial and Metabolic Plasticity Underlie Comorbidity Between Age-Related and Degenerative Disorders as Parkinson Disease and Type 2 Diabetes Mellitus,” Antioxidants (Basel) 9, no. 11 (2020): 1063.

[277] A. Rezaeinezhad, P. Eslami, H. Mirmiranpour, and H. Ghomi, “The Effect of Cold Atmospheric Plasma on Diabetes-induced Enzyme Glycation, Oxidative Stress, and Inflammation; in Vitro and in Vivo,” Scientific Reports 9, no. 1 (2019): 19958.

[278] S. Mirpour, S. Fathollah, P. Mansouri, et al., “Cold Atmospheric Plasma as an Effective Method to Treat Diabetic Foot Ulcers: A Randomized Clinical Trial,” Scientific Reports 10, no. 1 (2020): 10440.

[279] M. R. Amini, M. Sheikh Hosseini, S. Fatollah, et al., “Beneficial Effects of Cold Atmospheric Plasma on Inflammatory Phase of Diabetic Foot Ulcers; a Randomized Clinical Trial,” Journal of Diabetes & Metabolic Disorders 19, no. 2 (2020): 895-905.

[280] N. Abu Rached, S. Kley, M. Storck, T. Meyer, and M. Stücker, “Cold Plasma Therapy in Chronic Wounds—A Multicenter, Randomized Controlled Clinical Trial (Plasma on Chronic Wounds for Epidermal Regeneration Study): Preliminary Results,” Journal of Clinical Medicine 12, no. 15 (2023): 5121.

[281] S. Karrer, P. Unger, M. Gruber, et al., “In Vitro Safety Study on the Use of Cold Atmospheric Plasma in the Upper Respiratory Tract,” Cells 13, no. 17 (2024): 1411.

[282] S. Akhavan-Mahdavi, M. Mirzazadeh, Z. Alam, and S. Solaimanimehr, “The Effect of Chitosan Coating Combined With Cold Plasma on the Quality and Safety of Pistachio During Storage,” Food Science & Nutrition 11, no. 7 (2023): 4296-4307.

[283] M. J. Alam, A. Hamza Sadiq, J. Kristof, et al., “In Vitro Drug Delivery Through the Blood—Brain Barrier Using Cold Atmospheric Plasma,” Macromolecules 4 (2024): 597-609.

[284] H. Eguchi, Y. Yu, Y. Yoshino, H. Hara, H. Tanaka, and A. Ikari, “Plasma-activated Medium Ameliorates the Chemoresistance of human Lung Adenocarcinoma Cells Mediated via Downregulation of Claudin-2 Expression,” Archives of Biochemistry and Biophysics 751 (2024): 109846.

[285] P. Eisenhauer, N. Chernets, Y. Song, et al., “Chemical Modification of Extracellular Matrix by Cold Atmospheric Plasma-generated Reactive Species Affects Chondrogenesis and Bone Formation,” Journal of Tissue Engineering and Regenerative Medicine 10, no. 9 (2016): 772-782.

[286] O. V. Evgenov, P. Pacher, P. M. Schmidt, G. Haskó, H. H. H. W. Schmidt, and J.-P. Stasch, “NO-independent Stimulators and Activators of Soluble Guanylate Cyclase: Discovery and Therapeutic Potential,” Nature Reviews Drug Discovery 5, no. 9 (2006): 755-768.

[287] J. Winter, T. M. C. Nishime, S. Glitsch, H. Lühder, and K.-D. Weltmann, “On the Development of a Deployable Cold Plasma Endoscope,” Contributions to Plasma Physics 58, no. 5 (2018): 404-414.

[288] J. Van Loenhout, T. Flieswasser, L. Freire Boullosa, et al., “Cold Atmospheric Plasma-Treated PBS Eliminates Immunosuppressive Pancreatic Stellate Cells and Induces Immunogenic Cell Death of Pancreatic Cancer Cells,” Cancers 11, no. 10 (2019): 1597.

[289] Z. Wu, X. Jing, S. Xu, et al., “Plasma-Activated AVC Hydrogel for Reactive Oxygen and Nitrogen Species Delivery to Treat Allergic Contact Dermatitis,” ACS Applied Materials & Interfaces 16, no. 43 (2024): 58379-58391.

[290] J. De Oliveira Mallia, S. Griffin, C. Buttigieg, and R. Gatt, “A Rapid Prototyped Atmospheric Non-thermal Plasma-activated Aerosol Device and Anti-bacterial Characterisation,” Frontiers in Chemistry 12 (2024): 1416982.

[291] N. S. L. Chew, K. S. Wong, W. S. Chang, C. W. Ooi, L. Y. Yeo, and M. K. Tan, “Nanoscale Plasma-activated Aerosol Generation for in Situ Surface Pathogen Disinfection,” Microsystems & Nanoengineering 8 (2022): 41.

[292] X. Dai, Y. Dai, Y. Zheng, and Y.i Lv, “Magnetic Nanoparticles and Possible Synergies With Cold Atmospheric Plasma for Cancer Treatment,” RSC Advances 14, no. 40 (2024): 29039-29051.

[293] E. Manaloto, A. A. Gowen, A. Lesniak, et al., “Cold Atmospheric Plasma Induces Silver Nanoparticle Uptake, Oxidative Dissolution and Enhanced Cytotoxicity in Glioblastoma Multiforme Cells,” Archives of Biochemistry and Biophysics 689 (2020): 108462.

[294] J.-H. Choi, H.-J. Gu, K.-H.a Park, D.-S. Hwang, and G.-C. Kim, “Anti-Cancer Activity of the Combinational Treatment of Noozone Cold Plasma With p-FAK Antibody-Conjugated Gold Nanoparticles in OSCC Xenograft Mice,” Biomedicines 10, no. 9 (2022): 2259.

[295] M. Mladenov, L. Lubomirov, O. Grisk, et al., “Oxidative Stress, Reductive Stress and Antioxidants in Vascular Pathogenesis and Aging,” Antioxidants 12, no. 5 (2023): 1126.

[296] M. Mladenov, I. Sazdova, N. Hadzi-Petrushev, R. Konakchieva, and H. Gagov, “The Role of Reductive Stress in the Pathogenesis of Endocrine-Related Metabolic Diseases and Cancer,” International Journal of Molecular Sciences 26, no. 5 (2025): 1910.

RIGHTS & PERMISSIONS

2025 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.